Surgically resected tumor tissues from HER2+ BC patients treated with trastuzumab along with neoadjuvant chemotherapy (NAC) showed a significantly higher count of VM channels per unit area as compared to the respective controls [113]. This evidence concerns the gene ERBB2 and breast cancer.